Objective: The paper is to standardize the inpatient diagnosis and treatment process of percutaneous coronary intervention (PCI) and improve hospital management efficiency. Methods: A total of 380 patients grouped in FM19 from Jan. 1st 2021 to Dec. 31st 2021 from a first-class hospital in Beijing were analyzed. Mann-whitney U test, one-way ANOVA, multiple linear regression and other methods were used to analyze the factors influencing first page of inpatient medical records and total inpatient expenditure. Results: The per capita cost of 377 effective PCI patients is 46318.21 Yuan pairing with the quota of FM19 which is 59483 Yuan, and the difference value balance is 13184.66 Yuan. Average length of stay is 6.16. Proportion of drugs, operation and treatments are factors which do not have significance of difference value (P>0.05). The primary influencing factor is proportion of medical consumables (P<0.001) . Patients' private expenses and length of stay have negative effect on difference value balance (P<0.001) . Conclusion: Managing the cost of medical consumables is an effective measure for medical institutions to realize the balance of patients in PCI group. Standardizing the hospitalization process of PCI, establishing an effective clinical path, and controlling the use of private projects are important means.
Key words
DRG /
PCI /
difference value /
influence factors
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 北京市医疗保障局.北京市医疗保障局关于调整冠脉支架报销标准及开展CHS-DRG冠脉支架置入病组付费有关问题的通知[J].北京市人民政府公报,2021,07:66-69.
[2] 郭富威,任苒.DRGs在美国的发展及在我国的应用对策[J].中国医院管理,2006,02:32-35.
[3] 王坚强,王奕婷.DRG医保支付方式改革对医疗行为的影响[J].湖南社会科学,2021,01:133-139.
[4] 马冀,张欣,卢欣阳,罗蓟.基于DRG的心脏PCI术分组效果及费用影响因素分析[J].中国病案,2021,06:47-51.
[5] 刘珺,刘文奕,吴波,姚吉龙.基于科室与患者特点的平均住院日管控分析[J].医院管理论坛,2021,12:39-42.
[6] 方金鸣,刘玲,彭义香,陶红兵.DRG支付制度改革中医务人员诊疗行为调查研究[J].中国医院管理,2022,03:37-42.
[7] 江芹. DRG收付费政策设计与实施中的经验及启示[J].中国卫生经济,2022,01:6-11.
[8] 于丽华. 医改政策环境下医疗机构实施DRG的思路和策略[J].中国卫生经济,2022,01:12-16.
[9] 郎婧婧. DRG收付费政策的设计与实践[J].中国卫生经济,2022,01:83-87.
[10] 杨英,苏荣耀,吴勇,陈燕凌.DRG收付费改革对医院的影响及管理策略[J].中国卫生经济,2022,01:63-67.
[11] 张钰婉,谈在祥.DRG支付背景下公立医院运营管理问题与对策研究[J].中国医院管理,2022,01:49-52.
[12] 北京市医疗保障局,北京市卫生健康委员会,北京市药品监督管理局.关于印发北京市落实国家组织冠脉支架集中带量采购工作实施方案的通知[J].北京市人民政府公报,2021,07:59-65.
[13] 张少博,姚洪生,彭志涛.DRGs支付方式下耗材管控标准化分析流程研究[J].中国医疗设备,2022,01:151-154.
[14] 赵星涛. 疾病诊断相关支付下如何加强新技术新项目管理[J].中国药物与临床,2021,01:140-141.
[15] 张欣. 通过DRG数据指数化及标准化对住院费用细化分析与研究[J].中国医疗保险,2021,02:68-71.